A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients

The SARS-CoV-2 virus, caused a novel emerged coronavirus disease, is growing rapidly worldwide. Few studies have evaluated the efficacy and safety of Chloroquine (CQ), an old antimalarial drug, and Hydroxychloroquine (HCQ) in the treatment of COVID-19 infection. HCQ is derived from CQ by adding a hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Askarian, Fatemeh, Firoozi, Zahra, Ebadollahi-Natanzi, Alireza, Bahrami, Solmaz, Rahimi, Hamid-Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286988/
https://www.ncbi.nlm.nih.gov/pubmed/34306523
http://dx.doi.org/10.1007/s43188-021-00101-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286988/
https://www.ncbi.nlm.nih.gov/pubmed/34306523
http://dx.doi.org/10.1007/s43188-021-00101-5

Ejemplares similares